A study conducted at the University of Maryland School of Medicine in Baltimore provides the first direct evidence that cigarette smoke exposure prior to a heart transplant in either the donor, recipient, or both, accelerates the death of a transplanted heart.
The study, published this month in the journal Circulation, showed that tobacco smoke leads to accelerated immune system rejection of the transplanted heart, heightened vascular inflammation and increased oxidative stress, and a reduction in the transplanted organ's chance of survival by 33-57 percent.
The study, conducted in rats, involved exposure to levels of tobacco equivalent to that of a habitual, light-to-moderate-range smoker and included comparisons between smoking and non-smoking donors and recipients.
"Our research shows that if a heart donor has been a habitual smoker, and you put that heart in a non-smoking recipient, that heart won't work; it will be rejected," says the study's senior author, Mandeep R. Mehra, M.B.B.S., professor of medicine, head of the Division of Cardiology at the University of Maryland School of Medicine and chief of cardiology at the University of Maryland Medical Center. "This study shows beyond a shadow of a doubt how smoking affects transplantation."
This is the first study to look at the impact of smoking in heart donors, according to the principal investigator, Ashwani K. Khanna, Ph.D., associate professor of medicine at the University of Maryland School of Medicine. "There are already many risk factors that physicians and surgeons must consider when they try to match a donor with a recipient. This study makes clear that smoking in both the donor and the recipient should also become a part of the risk calculus in organ donation," says Dr. Khanna.
Studies from the mid-1990s have shown a connection between cigarette smoking and cardiovascular diseases. More recent studies have found a connection between smoking and the outcome of heart and other organ transplantation in recipients who resumed smoking after their transplants.
"The effects of smoking on heart health are well known and no surprise," says E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs at the University of Maryland and dean of the University of Maryland School of Medicine. "The surprise in this study is the extent of the deleterious effects of smoking on the transplanted heart. Our researchers have discovered a significant connection that may lead to new ways to help patients with heart transplants live longer," he says.
Study design and results
In this study, groups of donor and recipient rats were exposed to tobacco smoke while a control group of donors and recipients did not undergo any tobacco smoke exposure. Drugs are routinely used to prevent the body's immune system from attacking a transplanted organ. To better isolate the effect of smoking exposure from such factors as immunosuppression, the recipient rats in this study were not given medications to suppress their immune systems.
Transplanted hearts not exposed to tobacco were rejected an average of eight days after transplantation. Donor hearts exposed to cigarette smoke were rejected at five days, while recipient smoke exposure elicited rejection at four days. Hearts in which both the donor and recipient were exposed to tobacco smoke lasted just three days before the immune response began destroying the transplant.
The researchers underscore that reduced survival occurred regardless of whether the heart donor or recipient smoked. "This accelerated trajectory of organ loss is similar whether tobacco smoke exposure occurred in donors, recipients, or both before cardiac transplantation," says Dr. Mehra. Further, this reduced survival occurs in the midst of a cascade of processes that add up to a poor outcome: increased inflammation, immune system activation and the resulting destruction of the heart's muscular and vascular systems.
The researchers speculate that this cascade could be interrupted at the time of transplantation with focused drug intervention in the anti-inflammatory and antioxidant pathways. They suggest that an antioxidant such as n-acetyl cysteine or widely prescribed statins (anti-inflammatory drugs) could prove useful in inhibiting these adverse responses. Dr. Khanna says a study of these interventions is being planned.
This work was supported by a grant from the University of Maryland Statewide Health Network and a Tobacco-Related Diseases Research Grant through the Maryland Cigarette Restitution Fund Program.
Khanna AK, Xu J, Uber PA, Burke AP, Baquet C, Mehra MR. "Tobacco Smoke Exposure in Either the Donor or Recipient Before Transplantation Accelerates Cardiac Allograft Rejection, Vascular Inflammation, and Graft Loss." Circulation. Originally published online Oct 19, 2009.
Bill Seiler | EurekAlert!
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
Disarray in the brain
18.12.2017 | Universität zu Lübeck
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
19.01.2018 | Physics and Astronomy
19.01.2018 | Materials Sciences
19.01.2018 | Life Sciences